[go: up one dir, main page]

MX2009008166A - Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate. - Google Patents

Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.

Info

Publication number
MX2009008166A
MX2009008166A MX2009008166A MX2009008166A MX2009008166A MX 2009008166 A MX2009008166 A MX 2009008166A MX 2009008166 A MX2009008166 A MX 2009008166A MX 2009008166 A MX2009008166 A MX 2009008166A MX 2009008166 A MX2009008166 A MX 2009008166A
Authority
MX
Mexico
Prior art keywords
avocado
mammal
glucose
stress
antimetaboltes
Prior art date
Application number
MX2009008166A
Other languages
English (en)
Inventor
George Roth
Michael Griffin Hayek
Stefan Patrick Massimino
Gary Mitchell Davenport
Mark A Lane
Donald Ingram
Original Assignee
Iams Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company filed Critical Iams Company
Publication of MX2009008166A publication Critical patent/MX2009008166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

La presente invención está dirigida a un método para disminuir la inflamación y el estrés en un mamífero, que comprende; la administración de una composición que comprende un antimetabolito de glucosa a un mamífero; y en donde dicha composición comprende cantidades suficientes de antimetabolito de glucosa para disminuir un nivel de proteína C reactiva en la sangre del mamífero después de la administración del antimetabolito de glucosa.
MX2009008166A 2007-02-01 2008-01-31 Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate. MX2009008166A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89878807P 2007-02-01 2007-02-01
PCT/IB2008/050382 WO2008093303A2 (en) 2007-02-01 2008-01-31 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts

Publications (1)

Publication Number Publication Date
MX2009008166A true MX2009008166A (es) 2009-08-12

Family

ID=39494413

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008166A MX2009008166A (es) 2007-02-01 2008-01-31 Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.

Country Status (13)

Country Link
US (1) US9415083B2 (es)
EP (1) EP2124966B1 (es)
JP (2) JP5799299B2 (es)
CN (1) CN101711158A (es)
AR (1) AR065145A1 (es)
AU (1) AU2008211600B8 (es)
BR (1) BRPI0808391A2 (es)
CA (1) CA2673465A1 (es)
ES (1) ES2551719T3 (es)
MX (1) MX2009008166A (es)
PL (1) PL2124966T3 (es)
RU (1) RU2436581C2 (es)
WO (1) WO2008093303A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011160255A1 (en) 2010-06-23 2011-12-29 Gm Global Technology Operations, Inc. Vehicle procession control through a traffic intersection
FR2969496B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de pulpe et/ou de peau d'avocat riche en polyphenols et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
US20120283197A1 (en) * 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
MX378054B (es) 2013-03-15 2025-03-10 Colgate Palmolive Co Composiciones para el cuidado oral que contienen antimetabolitos de desoxiazúcar.
EP2990035B1 (en) * 2013-04-15 2018-03-07 National University Corporation University Of Toyama 1,5-anhydro-d-glucitol-containing collagen production accelerator
TWI605822B (zh) * 2015-04-09 2017-11-21 高雄醫學大學 酪梨萃取物、ａｖｏｃａｄｅｎｏｌ Ｂ及（２Ｒ，４Ｒ）－１，２，４－三羥基十七碳－１６－炔的用途，以及包含酪梨萃取物之保健食品
CA3049952A1 (en) 2017-07-26 2019-01-31 Tgx Soft Chew, Llc Starch-free soft chew for veterinary applications
CN116350642B (zh) * 2023-02-28 2025-10-17 中南民族大学 1,6-脱水-β-D-葡萄糖制备用于维持结肠上皮屏障和隐窝的完整性以及抗结肠炎的药品的应用

Family Cites Families (387)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US571521A (en) 1896-11-17 Package for powders
US1086936A (en) 1913-05-15 1914-02-10 Malcolm Pounder Dental massage implement.
US1503094A (en) 1923-09-15 1924-07-29 Cramerton Mills Inc Warp condenser
US2473773A (en) 1945-11-16 1949-06-21 Eleanor Kushmaul Toothbrush
US2540979A (en) 1948-04-24 1951-02-06 Smith Kline French Lab Enteric coating
US2641548A (en) * 1950-04-06 1953-06-09 Helen W Heinrich Method of preserving avocados
NL294835A (es) 1962-07-19 1900-01-01
US3398001A (en) * 1963-04-26 1968-08-20 Air Reduction Process of preparing and packaging frozen avocados
DE1204363B (de) 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1190387A (en) 1966-05-24 1970-05-06 Green Cross Corp Enteric Coated Medicaments
DE1536074A1 (de) 1966-06-28 1969-11-13 Hoefliger & Karg Tiefziehpackung
US3677898A (en) * 1969-01-31 1972-07-18 Ajinomoto Kk Acid protease and method of preparing the same
US3898132A (en) 1972-08-24 1975-08-05 Int Feed Improvement Ass Inc Method of preparing stowable, dormant bacteria
US3931885A (en) 1973-04-30 1976-01-13 Nahill Edmond P Medicine dispensing system
US3897572A (en) 1973-05-16 1975-07-29 Star Kist Foods Formed meat product
US3989822A (en) 1974-02-14 1976-11-02 Purdue Research Foundation Weight control compound
US3957974A (en) 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS6038372B2 (ja) 1975-04-09 1985-08-31 日清製粉株式会社 犬の下痢予防および治療方法
JPS52102419A (en) 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
GB1595054A (en) 1977-11-14 1981-08-05 Metal Box Co Ltd Capsules containing micro-organisms
IL58649A (en) 1978-11-10 1982-04-30 Beecham Group Ltd Pharmaceutical dispensing container
CH637297A5 (fr) 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
US4338346A (en) 1978-12-21 1982-07-06 The Procter & Gamble Company Non-nutritive sweetener
FR2453215A1 (fr) 1979-04-05 1980-10-31 Rhone Poulenc Ind Procede d'inclusion de micro-organismes dans une matrice de polymere
US4248857A (en) 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4411925A (en) 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
US4399163A (en) 1980-11-05 1983-08-16 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
US4423029A (en) 1981-06-25 1983-12-27 The Procter & Gamble Company (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners
US4403623A (en) 1981-11-16 1983-09-13 Colgate-Palmolive Company Combined toothbrush and gum massage device
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
JPS6024153Y2 (ja) 1982-07-20 1985-07-18 山陽菓機工業有限会社 食品製造工程に於る油塗布装置
NL8203297A (nl) 1982-08-24 1984-03-16 Philips Nv Weerstandslichaam.
US4518696A (en) 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
JPS59213368A (ja) 1983-05-17 1984-12-03 Hanamaruki Kk 果実食品およびその製造法
US4736849A (en) 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4592748A (en) 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
CA1276394C (en) 1984-07-13 1990-11-13 John M. Janusz Alpha-l-aspartyl-d-phenylglycine esters and amides useful as high intensity sweeteners
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
JPS61109729A (ja) 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
SE463598B (sv) 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
EP0212746B1 (en) 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
DE3678644D1 (de) 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
JPS6297221A (ja) * 1985-10-22 1987-05-06 ウチヤ・サ−モスタツト株式会社 可変型温度調節器
JPS6297221U (es) 1985-12-09 1987-06-20
US4764389A (en) 1986-04-24 1988-08-16 Labarge Universal Ripener, Inc. Method of accelerating fruit respiration
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
JPH041402Y2 (es) 1986-06-16 1992-01-17
CA1300538C (en) 1986-08-01 1992-05-12 Robert Charley Maintenance of the viability of microorganisms for use in microbial inoculants
US4808626A (en) * 1986-09-23 1989-02-28 Monell Chemical Senses Center Use of 2,5-anhydro-D-mannitol as a food intake modifier
US4781939A (en) 1986-10-28 1988-11-01 Nestec, S.A. Layered meat emulsion product and method of producing same
US4816259A (en) 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US4797289A (en) 1987-03-09 1989-01-10 Reddy Malireddy S Enhancement of lactobacillus acidophilus growth and viability in yogurt and other cultured dairy products
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
AU620807B2 (en) 1987-05-01 1992-02-27 Biogaia Biologics Ab Antibiotic reuterin
DE3715070A1 (de) 1987-05-06 1988-11-17 Kneipp Werke Kneipp Mittel Zen Verfahren zur herstellung von pflanzenauszuegen, insbesondere von pflanzensaeften
FI77573C (fi) 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
FR2615203B1 (fr) 1987-05-12 1989-08-18 Agronomique Inst Nat Rech Inoculum dans lequel les micro-organismes sont conditionnes sous la forme de granules biodegradables, son procede de preparation et ses applications
GB8713601D0 (en) 1987-06-10 1987-07-15 Unilever Plc Fermentation
US4859377A (en) 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens
US4806368A (en) 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
US4937077A (en) 1987-09-21 1990-06-26 Eastman Kodak Company Method for improving feed conversion of meat-producing animals by oral administration of 2-deoxy-D-hexose
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
US4814193A (en) * 1988-04-06 1989-03-21 General Foods Corporation Reduction of microbial population on surface of food materials
US5126153A (en) * 1988-05-13 1992-06-30 Basic American Foods, Inc. Compositions and methods for inhibiting browning of processed produce
CA1333564C (en) 1988-08-02 1994-12-20 Thomas Julius Borody Treatment of gastro-intestinal disorders
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US4889238A (en) 1989-04-03 1989-12-26 The Procter & Gamble Company Medicament package for increasing compliance with complex therapeutic regimens
AU5254790A (en) 1989-04-06 1990-10-11 Chugai Seiyaku Kabushiki Kaisha Process for preparing a therapeutic agent for rotavirus infection
US5540945A (en) 1989-05-11 1996-07-30 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
PT94108A (pt) 1989-05-24 1991-02-08 Asahi Chemical Ind Preparacao de microorganismos viaveis contendo esporos estabilizada,sua producao e pilulas respectivas
PH27186A (en) 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DE3933528C1 (es) 1989-10-04 1990-12-06 Effem Gmbh, 2810 Verden, De
SE465206B (sv) 1989-12-22 1991-08-12 Eva Grahn Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
US5198227A (en) 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5344824A (en) * 1990-02-02 1994-09-06 Matsutani Chemical Industries Co., Ltd. Method for reducing insulin secretion
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
DK203090A (da) 1990-02-28 1991-08-29 Sitia Yomo Spa Maelkeagtig mousse, dens tilberedning og anvendelse
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
DE4018392A1 (de) 1990-06-08 1991-12-12 Kaysan Rolf Dipl Kaufm Verfahren zur gewinnung von pflanzen-hydrolysaten insbesondere fuer biokosmetische und pharmazeutische zwecke
FR2663198B1 (fr) 1990-06-14 1993-09-17 Xeda International Utilisation de composes antioxydants pour augmenter la resistance des fruits et legumes contre les infections fongiques.
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
FR2668081B1 (fr) 1990-10-19 1994-11-18 Lvmh Rech Procede et appareil de fabrication de particules solides a partir d'un materiau solidifiable en presence d'un agent de solidification en de bons rendements.
US5292657A (en) 1990-12-31 1994-03-08 Pioneer Hi-Bred International, Inc. Process for preparing rotary disc fatty acid microspheres of microorganisms
IT1244691B (it) 1991-01-29 1994-08-08 Sitia Yomo Spa Mousse lattea, suo impiego per preparare dessert e dessert cosi' ottenuti
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
FR2678166B1 (fr) 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
WO1993002558A1 (en) 1991-08-01 1993-02-18 Biogaia Biologics Ab Method and formulation for reducing microbial populations
GB2261372A (en) 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
EP0563934A1 (de) 1992-04-03 1993-10-06 Dr. Karl Thomae GmbH Blisterstreifen aus Kunststoff-Folien mit Doppel-bzw. Mehrfachdosierung.
US5286495A (en) 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
ES2102485T3 (es) 1992-07-06 1997-08-01 Nestle Sa Bacteria lactica.
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
US5501857A (en) 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
HU220103B (hu) 1992-08-20 2001-10-28 Schering-Plough Corp. IL-10 új alkalmazása
US5403799A (en) 1992-12-21 1995-04-04 W. R. Grace & Co.-Conn. Process upset-resistant inorganic supports for bioremediation
JP3347381B2 (ja) 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
JP3472317B2 (ja) 1993-02-26 2003-12-02 味の素ファルマ株式会社 被覆製剤
EP0706400A1 (en) 1993-03-15 1996-04-17 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
NZ263411A (en) 1993-03-16 1997-08-22 Us Agriculture Method for the preparation of composition for poultry, against salmonella and campylobacter
IT1265092B1 (it) 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
GB9315846D0 (en) 1993-07-30 1993-09-15 Isis Innovation Tumour inhibitors
GB9318439D0 (en) 1993-09-06 1993-10-20 Zeneca Ltd Probiotics
US5501868A (en) 1993-09-21 1996-03-26 Colgate Palmolive Company Extruded dog treat food product having improved resistance to breakage
DE4336050C2 (de) 1993-10-22 1995-11-16 Onken Gmbh Tierfutter, insbesondere Alleinfutter für Katzen und Hunde
US5733568A (en) 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
JP3559790B2 (ja) 1993-12-20 2004-09-02 松谷化学工業株式会社 食品にビフィズス菌の増殖促進作用を付与する方法
US5486507A (en) 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
JPH07232049A (ja) 1994-02-25 1995-09-05 Freunt Ind Co Ltd 遠心転動造粒コーティング装置および粉粒体の遠心転動造粒コーティング方法ならびにその方法を用いた粉粒体の造粒方法とコーティング方法
JP2992945B2 (ja) 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
US5894029A (en) 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
SE9401738D0 (sv) 1994-05-19 1994-05-19 Ewos Ab Bioactive feed
IT1270216B (it) 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5849327A (en) 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5531988A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5733540A (en) 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
JPH08242763A (ja) 1995-03-10 1996-09-24 Morishita Jintan Kk カプセル化された腸内有用細菌を含有するヨーグルト
CR5278A (es) 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
IT1276783B1 (it) 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
US5785990A (en) 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
FI102298B (fi) 1995-09-07 1998-11-13 Oulutech Oy Menetelmä maitohappobakteerilajien määrittämiseksi ja menetelmään sove ltuvia oligonukleotideja
US6506389B2 (en) 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
US5853697A (en) 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
AT405235B (de) 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
AUPN698495A0 (en) 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
US5858356A (en) 1995-12-21 1999-01-12 Abbott Laboratories Lactobacillus acidophilus to inhibit cryptosporidiosis in mammals
US5854067A (en) 1996-01-19 1998-12-29 Board Of Regents, The University Of Texas System Hexokinase inhibitors
US5962043A (en) 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
GB2311027B (en) 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
RU2086248C1 (ru) 1996-04-02 1997-08-10 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Пробиотический препарат "стрептобифид" для животных
US5824779A (en) 1996-04-26 1998-10-20 Wisconsin Alumni Research Foundation Phytase-protein-pigmenting concentrate derived from green plant juice
US5766520A (en) 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
DK0818529T3 (da) 1996-07-09 2005-10-17 Nestle Sa Fremgangsmåde til spraytörring
US5871794A (en) * 1996-08-07 1999-02-16 Brito; Jorge Issac Stabilized guacamole and method for making same
US5660790A (en) 1996-08-13 1997-08-26 Litmus Concepts, Inc. PH and amine test elements
DE69730982T2 (de) 1996-10-28 2005-09-01 General Mills, Inc., Minneapolis Einbettung und einkapselung von teilchen zur kontrollierten abgabe
ZA979937B (en) 1996-11-06 1999-05-18 Sharmatek Inc Delayed delivery system for acid-sensitive drugs
AU5113798A (en) 1996-11-29 1998-06-22 Bio K & International Inc. Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof
AU5310898A (en) 1996-12-20 1998-07-17 Dumex-Alpharma A/S Release-controlled coated tablets
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
PT862863E (pt) 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
MXPA99007378A (es) 1997-02-11 2005-04-19 Entpr Ireland Cepas probioticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de lasmismas.
US6133323A (en) 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
DE69842080D1 (de) 1997-04-18 2011-02-10 Ganeden Biotech Inc Oberflächige Verwendung von probiotischen Bacillussporen zur Verhinderung oder Bekämpfung von mikrobiellen Infektionen
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
PT986314E (pt) 1997-06-03 2008-12-30 Ganeden Biotech Inc Bactéria láctica probiótica para tratar infecções bacterianas associadas à sids
IT1292636B1 (it) 1997-06-20 1999-02-08 Ascor Chimici Srl Composizione a rilascio controllato di sostanze biologicamente attive ad uso zootecnico.
RU2123343C1 (ru) 1997-06-26 1998-12-20 Алин Борис Иннокентьевич Способ получения капсул, содержащих бактерии b.bifidum (бифидумбактерин сухой в капсулах)
US5976579A (en) 1997-07-03 1999-11-02 Mclean; Linsey Nutritional supplement for the prevention and treatment of excessive intestinal permeability
US20180000880A9 (en) 1997-07-08 2018-01-04 The Iams Company Methods of treating or preventing overweight and obsesity in mammals by administering a composition comprising mannoheptulose
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6077530A (en) 1997-07-28 2000-06-20 Weinstein; Robert Analgesic dosage units for coordinated administration
US5939117A (en) * 1997-08-11 1999-08-17 Mantrose-Haeuser Co., Inc. Methods for preserving fresh fruit and product thereof
US6063414A (en) 1997-08-18 2000-05-16 Seal Rock Technologies Incorporated Combination container and dry pet food for increased shelf life, freshness, palatability, and nutritional value
FI108512B (fi) 1997-08-22 2002-02-15 Danisco Finland Oy Tahnamainen nautittavaksi tarkoitettu koostumus, sen käyttö ja sitä sisältävät tuotteet
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
JP3400685B2 (ja) 1997-09-04 2003-04-28 矢崎総業株式会社 インサート成形によるターミナルの製造方法
KR100387245B1 (ko) 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
US5871802A (en) 1997-12-16 1999-02-16 Moorman Manufacturing Co. Animal feed pelleting process and animal feed pellets produced therefrom
AR014129A1 (es) 1997-12-17 2001-02-07 Nutrasweet Co Bebida que comprende fundamentalmente un ester n-[n-(3,3-dimetilbutil)-l- alfa-aspartil]-l-fenilamina 1 - metilico, bebida sin alcohol carbonatada,bebida de jugo, bebida envasada caliente y bebida deportiva de bajas calorias.
EP0931543B1 (de) 1997-12-19 2002-03-20 MERCK PATENT GmbH Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
US6117477A (en) 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
DK1065936T3 (da) 1998-03-23 2009-11-02 Gen Mills Inc Indkapsling af bestanddele i spiselige produkter
FI104405B (fi) 1998-03-27 2000-01-31 Valtion Teknillinen Mikro-organismeja sisältävät tärkkelyskapselit ja niiden valmistusmenetelmä
US5932258A (en) 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
DE69802260T2 (de) 1998-04-30 2002-07-04 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
DE19819475A1 (de) 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
WO2000006127A1 (en) 1998-07-30 2000-02-10 Warner-Lambert Company Centerfill delivery system for nutraceuticals
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
US6156355A (en) 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
IT1304170B1 (it) 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
JP2000191519A (ja) 1998-12-25 2000-07-11 Nippon Kayaku Co Ltd 薬効成分の不快な官能的性質が隠蔽された速放性粒状物
DE19860375A1 (de) * 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6767573B1 (en) 1999-03-10 2004-07-27 Nestec S.A. Fried pet treats
US6692779B2 (en) 1999-03-26 2004-02-17 The Pillsbury Company Food products with biocontrol preservation
US6358555B1 (en) * 1999-03-31 2002-03-19 Hideyuki Takahashi Process for producing frozen avocados
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
AU767764C (en) 1999-05-27 2005-08-18 Mars, Incorporated Process and product for enhancing immune response in companion animal using a combination of antioxidants
US6375956B1 (en) 1999-07-22 2002-04-23 Drugtech Corporation Strip pack
DE19937361A1 (de) 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
EP1213970B1 (en) 1999-09-07 2008-06-11 Societe Des Produits Nestle S.A. Method for improving the skin and coat of pets
WO2001021008A2 (en) 1999-09-22 2001-03-29 Societe Des Produits Nestle S.A. Method for increasing pet activity
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
DE60018591T2 (de) 1999-10-26 2006-04-13 Société des Produits Nestlé S.A. Milchsäurebakterien zur behandlung und prophylaxe von giardiasis
US6394803B1 (en) 1999-12-09 2002-05-28 Ivoclar Ag Mixing arrangement
JP2003517830A (ja) 1999-12-23 2003-06-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア カロリー制限の効果を模倣するための介入
US6406853B1 (en) 1999-12-23 2002-06-18 The Regents Of The University Of California Interventions to mimic the effects of calorie restriction
US20010036488A1 (en) 2000-01-18 2001-11-01 Syuichi Hayashi Anti-obestic composition
ATE542434T1 (de) 2000-01-18 2012-02-15 Nestle Sa Haustierfutterzusammensetzung zur behandlung der helicobacter spezies in haustieren
US20030060503A1 (en) 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
JP3888064B2 (ja) 2000-01-27 2007-02-28 田辺製薬株式会社 徐放性製剤およびその製法
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
JP2001309753A (ja) 2000-04-28 2001-11-06 Natl Fedelation Of Agricult Coop Assoc 犬特有の感染症の予防・治療用ドッグフード
US20030104090A1 (en) 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
ES2262667T3 (es) 2000-05-25 2006-12-01 Societe Des Produits Nestle S.A. Probioticos nuevos para aplicaciones en alimento para animales de compañia.
DE10029079B4 (de) 2000-06-13 2006-04-20 Mars Inc. Probiotische Mikroorganismen enthaltendes Nahrungsmittelerzeugnis
US6746672B2 (en) 2000-06-19 2004-06-08 Regents Of The University Of Minnesota Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis
AU2001272369A1 (en) 2000-07-17 2002-01-30 Chr. Hansen A/S Methods and formultations with probiotic microorganisms and medicaments
CN1268351C (zh) * 2000-08-01 2006-08-09 奥力榨油化株式会社 糖类吸收抑制剂及其制备方法
US6592863B2 (en) 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
WO2002016554A1 (en) 2000-08-25 2002-02-28 Wakamoto Pharmaceutical Co.,Ltd. Probiotics products containing lactic acid bacterium
JP2004514424A (ja) 2000-09-25 2004-05-20 ソシエテ　デ　プロデユイ　ネツスル　ソシエテ　アノニム アレルギー反応を起こす個人の傾向を減少させることができる乳酸菌
MXPA03002957A (es) 2000-10-06 2005-06-30 Nestle Sa Uso de bacteria probiotica de acido lactico para balancear el sistema inmune de la piel.
WO2003045356A1 (en) 2000-11-20 2003-06-05 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US6802422B2 (en) 2000-12-12 2004-10-12 Multi-Comp, Inc. Sealed blister assembly
US6797266B2 (en) 2000-12-18 2004-09-28 Probiohealth Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945
KR20020050048A (ko) 2000-12-20 2002-06-26 박흥재 Lactobacillus sp.DW-1 동정 시스템
US20020119237A1 (en) 2000-12-22 2002-08-29 Hevey Maurice O. Medium and method for delivery of edible materials subject to degradation by oxidation and hydrolysis
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US20030190314A1 (en) 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
EP1227152A1 (en) 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
US6588180B2 (en) 2001-02-02 2003-07-08 R. P. Scherer Technologies, Inc. Constricted neck blister pack and apparatus and method for making the same
ATE375164T1 (de) 2001-02-06 2007-10-15 Nestle Sa Endotoxin-bindung durch milchsäurebakterien und bifidobacteria
PL205155B1 (pl) 2001-02-19 2010-03-31 Nestle Sa Jadalny suchy produkt oraz sposób jego wytwarzania
US6586027B2 (en) * 2001-02-23 2003-07-01 T.F.H. Publications, Inc. Health chew toy
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
MXPA03007802A (es) 2001-03-09 2003-12-08 Nestle Sa Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad.
EP1372614A4 (en) * 2001-03-16 2007-10-31 Andrx Pharmaceuticals Llc SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
EP1373475A2 (en) 2001-04-02 2004-01-02 Alimentary Health Limited Immunotherapy based on dendritic cells
WO2002085415A1 (en) 2001-04-17 2002-10-31 Biomatrix, Inc Non-digestible sugar-coated products and process
EP1260227A1 (en) 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
US7081478B2 (en) 2001-06-29 2006-07-25 Chrysantis, Inc. Mixed zeaxanthin ester concentrate and uses thereof
EP1277412A1 (en) * 2001-07-17 2003-01-22 Societe Des Produits Nestle S.A. Pet food composition for regulating body weight and preventing obesity and related disorders in pets
PE20030274A1 (es) 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
PE20030284A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
PE20030283A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
RU2324367C2 (ru) 2001-09-18 2008-05-20 Нестек С.А. Корм для домашних животных и способ его производства
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
US6624162B2 (en) 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators
US6896914B2 (en) * 2001-10-26 2005-05-24 David I. Chapnick Method for normalizing insulin levels
US20050164978A1 (en) 2001-10-26 2005-07-28 Chapnick David I. Method for normalizing insulin levels
US20050079244A1 (en) 2001-11-12 2005-04-14 Giffard Catriona Julie Foodstuff
EP1994837A3 (en) 2001-11-16 2009-11-11 Nestec S.A. Plant derived or derivable material with appetite suppressant activity
EP1319410A1 (en) 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
EP1471797B1 (en) 2002-01-15 2008-03-05 Mars Incorporated Methods and products produced thereby to stabilize multi-layer food products
US20030143293A1 (en) 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
PL372274A1 (en) 2002-02-21 2005-07-11 Societe Des Produits Nestle S.A. A photoprotective orally administrable composition for skin
EP1344458A1 (en) 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
DE10217970A1 (de) 2002-04-22 2003-11-13 Henkel Kgaa Durchdrückverpackung
DE10213280A1 (de) 2002-03-25 2003-10-23 Mars Inc Proteinhaltiges Nahrungsmittelerzeugnis und Verfahren zu seiner Herstellung
US6681935B1 (en) 2002-04-02 2004-01-27 Graham L. Lewis Method of providing a therapeutic regimen and prefabricated container therefor
ATE492166T1 (de) 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren
US20030194423A1 (en) 2002-04-15 2003-10-16 Mars, Inc. Composition for enhancing nutritional content of food
US20040001817A1 (en) 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
EP1364586A1 (en) 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US8142810B2 (en) 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
GB0212975D0 (en) 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
US6733795B2 (en) * 2002-07-30 2004-05-11 Laboratoires Expanscience Method for producing an avocado leaf extract rich in furanic lipids
WO2004012752A2 (fr) * 2002-07-30 2004-02-12 Laboratoires Expanscience Procede d'obtention d'un extrait de feuilles d'avocatier riche en lipides furaniques
US20050208163A1 (en) 2002-07-31 2005-09-22 Brovelli Ernesto A Compositions containing avocado leaf extract for lowering cholesterol levels
KR20040024774A (ko) 2002-09-16 2004-03-22 이성표 혈액형별 체질에 적합하도록 제조한 생약 조성물
JP2004173675A (ja) 2002-10-02 2004-06-24 Takayuki Hirano 耐化学剤性を有する菌封入物および製造方法
WO2004045596A1 (en) * 2002-11-15 2004-06-03 Warner-Lambert Company Llc Method of lowering crp and reducing systemic inflammation
FR2848115B1 (fr) 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
US6835397B2 (en) 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US6979675B2 (en) 2003-01-10 2005-12-27 Threshold Pharmaceuticals, Inc. Treatment of cancer with 2-deoxyglucose
US7122370B2 (en) 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
GB0303716D0 (en) 2003-02-18 2003-03-19 Mars Uk Ltd Food product and process
US8030279B2 (en) 2003-03-21 2011-10-04 The Trustees Of The University Of Pennsylvania Tamandarin analogs and fragments thereof and methods of making and using
CA2519978A1 (en) 2003-03-25 2004-11-25 General Mills, Inc. Method of treating avocados and method of preparing guacamole therefrom
GB0308104D0 (en) 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
US20040265279A1 (en) 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
US20040234579A1 (en) 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
FR2855374B1 (fr) 2003-05-26 2007-06-01 Roquette Freres Procede de drageification dure ameliore
US20060147962A1 (en) 2003-06-16 2006-07-06 Mars, Inc. Genotype test
CN1863463B (zh) 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
JP2007530417A (ja) 2003-07-01 2007-11-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 細胞及び生物の寿命及びストレス応答を操作するための組成物
US7235276B2 (en) 2003-09-24 2007-06-26 General Mills Ip Holdings Ii, Llc High protein puffed food product and method of preparation
US20050074519A1 (en) 2003-10-01 2005-04-07 Sensient Flavors Inc. Method for the production of natural botanical extracts
GB0323668D0 (en) 2003-10-09 2003-11-12 Nestec Sa Fat-based confectionery product coated with a film forming agent making it resistant to heat and shape stable to heat
US20050100559A1 (en) 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US7687077B2 (en) 2003-11-26 2010-03-30 Hill's Pet Nutrition, Inc. Method to reduce stool odor of companion animals
AU2004294986B2 (en) * 2003-11-26 2010-09-09 Hill's Pet Nutrition, Inc. Method to reduce stool odor of companion animals
PL380446A1 (pl) 2003-12-18 2007-02-05 Nestec S.A. Kompozycja zawierająca flawanony do polepszania stanu zdrowia skóry, włosów lub sierści i futra
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
TW200524539A (en) 2003-12-23 2005-08-01 Rohm & Haas A method to reverse ethylene inhibitor responses in plants
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
DE102004004030A1 (de) 2004-01-27 2005-08-18 Mars Inc. Nahrungsmittelerzeugnis und Verfahren zu dessen Herstellung
US7303771B2 (en) * 2004-03-15 2007-12-04 Stephen Truesdale Carney Alfalfa sprout powder based supplement
WO2005089436A2 (en) 2004-03-16 2005-09-29 The Regents Of The University Of California Genetic networks regulated by attenuated gh/igf1 signaling and caloric restriction
GB0406654D0 (en) 2004-03-24 2004-04-28 Mars Inc Foodstuff
EP1745142A4 (en) 2004-04-20 2008-07-16 Univ Chicago PROBIOTIC COMPOUNDS FROM LACTOBACILLUS GG AND ITS USE
FR2869543B1 (fr) 2004-04-30 2006-07-28 Expanscience Laboratoires Sa Medicament comprenant un extrait peptidique d'avocat destine au traitement et la prevention des maladies liees a une deficience du systeme immunitaire
FR2869541B1 (fr) * 2004-04-30 2007-12-28 Expanscience Sa Lab Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee
US9089576B2 (en) 2004-04-30 2015-07-28 Laboratoires Expanscience Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
CA2569249C (en) 2004-05-10 2012-08-14 The Iams Company Processes for preparing plant matter extracts and pet food compositions
US20090252834A1 (en) 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20080044481A1 (en) 2004-05-27 2008-02-21 Mordechai Harel Microparticles for Oral Delivery
JP2005348698A (ja) 2004-06-14 2005-12-22 Yonezawa Biru System Service:Kk ケフィア粒から分離された微生物とこの微生物あるいはそれを含む微生物群を培養して得られる微生物培養物ならびにそれらを用いた製品
KR20070034591A (ko) * 2004-06-17 2007-03-28 위스콘신 얼럼나이 리서어치 화운데이션 발작 및 발작병을 치료하기 위한 화합물 및 방법
US20080305210A1 (en) 2004-07-01 2008-12-11 General Mills, Inc. Cultures Encapsulated With Compound Fat Breakfast Cereals Coated With Compound Fat and Methods of Preparation
JP5667737B2 (ja) 2004-07-01 2015-02-12 ネステク ソシエテ アノニム イヌ変形性関節症食餌製剤
US7935334B2 (en) 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060008511A1 (en) 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
US20060029685A1 (en) 2004-07-30 2006-02-09 Henderson Todd R Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
US20060070895A1 (en) 2004-08-16 2006-04-06 Faisal Khawaja Drug administration kit
JP2006055145A (ja) 2004-08-19 2006-03-02 Kosshi:Kk ペットフード及びペットフードの提供方法
DE602004013441T2 (de) 2004-09-21 2009-06-04 Nestec S.A. Verbesserung der Lebensdauer alter Katzen
US20070286935A1 (en) 2004-10-07 2007-12-13 Nestec S.A. Bioactive Compositions, Natural Methods of Producing Them and Computational Methods for Designing Natural Production Processes
FR2876876B1 (fr) 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite
FR2876875B1 (fr) 2004-10-22 2007-02-02 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par encapsulation
CA2589995C (en) 2004-12-17 2016-01-05 Alan B. Cash Oxaloacetate, oxaloacetic acid, and oxaloacetate salts for treating cancer
RU2007133511A (ru) 2005-02-10 2009-03-20 Фирмениш Са (Ch) Обработанный теплом пищевой продукт с покрытием из инкапсулированных вкусоароматических веществ
US20100233312A9 (en) 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US20060228459A1 (en) 2005-04-11 2006-10-12 The Iams Company Compositions comprising a cocoa butter component and an animal-derived fat component
US20060228448A1 (en) 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
EP2401924A1 (en) 2005-05-11 2012-01-04 Hill's Pet Nutrition, Inc. Methods for enhancing palatability of compositions for animal consumption
US20090263542A1 (en) 2005-05-13 2009-10-22 Charlie Hungwei Lin Dry Food Compositions Having Enhanced Palatability
EP1885203B1 (en) 2005-05-20 2018-01-03 Hill's Pet Nutrition, Inc. Methods for promoting health or wellness in adult animals
US9480275B2 (en) 2005-05-20 2016-11-01 Mars Incorporated Coated pet food products
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
RU2007149352A (ru) 2005-06-01 2009-07-20 Хилл`С Пет Ньютришн, Инк. (Us) Способы улучшения вкуса композиций для потребления животным
AT501919B1 (de) 2005-06-14 2008-09-15 Erber Ag Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung
US20070009577A1 (en) 2005-07-05 2007-01-11 Mankovitz Roy J Probiotic compositions and methods
US20070149466A1 (en) 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
EP1906912B1 (en) 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
US20070122531A1 (en) 2005-09-01 2007-05-31 Wellmark International Methods for Selecting a Pet-Appropriate Product
US8865197B2 (en) 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
GB0519164D0 (en) 2005-09-20 2005-10-26 Mars Inc Composition
RU2388320C2 (ru) 2005-09-30 2010-05-10 Хилл'С Пет Ньютришн, Инк. Способы увеличения срока хранения пищевых композиций, содержащих полиненасыщенные жирные кислоты
JP4198728B2 (ja) 2005-09-30 2008-12-17 株式会社グローバルエンジニアリング 動物用免疫活性調整剤、及びその調整剤を含有する動物用飼料
DE602006015665D1 (de) 2005-10-06 2010-09-02 Nestec Sa Probiotische enterokokken für eine verbesserte immunität
US20070280964A1 (en) 2005-10-06 2007-12-06 Ruth Knorr Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
US20070082107A1 (en) 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
US20090324761A1 (en) 2005-10-19 2009-12-31 Hill's Pet Nutrition, Inc. Methods And Compositions for Improving Gastrointestinal Health
US7647098B2 (en) 2005-10-31 2010-01-12 New York University System and method for prediction of cognitive decline
BRPI0618207A2 (pt) 2005-11-04 2011-08-23 Hills Pet Nutrition Inc método para melhorar a qualidade das fezes, composição, kit, meios para comunicar informações ou instruções, e, método para produzir uma composição para consumo animal
FR2893628B1 (fr) * 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
WO2007060539A2 (en) 2005-11-28 2007-05-31 Jorrocks Pty Ltd. Methods for preparation of animal feeds
CA2631401C (en) 2005-12-02 2013-01-29 Hill's Pet Nutrition, Inc. Methods for altering stool quality and/or stool frequency
WO2007076534A1 (en) 2005-12-29 2007-07-05 Hill's Pet Nutrition, Inc. Method for modifying gut flora in animals
DE102006001554A1 (de) 2006-01-05 2007-07-12 Ipc Process-Center Gmbh & Co. Micropellets für die Herstellung von Tiernahrungspellets
DE102006001553A1 (de) 2006-01-05 2007-07-19 Ipc Process-Center Gmbh & Co. Teilchen mit darin enthaltener empfindlicher Komponente
WO2007081981A2 (en) 2006-01-11 2007-07-19 Attune Foods Probiotic food, process for its preparation and dietary regimen
US20070166295A1 (en) 2006-01-13 2007-07-19 Vet Solutions L.P. Anti-Diarrhea Preparations for Small Domestic Animals
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
AU2007211625B2 (en) 2006-02-01 2012-08-23 Nestec S.A. Nutritional system and methods for increasing longevity
PL1986669T3 (pl) 2006-02-15 2012-09-28 Nestec Sa Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
US7960605B2 (en) 2006-03-17 2011-06-14 BioMaker Pharmaceuticals, Inc. Methods for testing for caloric restriction (CR) mimetics
ES2688934T3 (es) 2006-03-29 2018-11-07 Nestec S.A. Suplementos alimentarios que contienen probióticos
US20070231414A1 (en) 2006-03-29 2007-10-04 Kaneka Corporation Composition having bone resorption inhibition-related effect and method for inhibiting bone resorption
WO2007137808A1 (en) 2006-05-29 2007-12-06 University College Dublin, National University Of Ireland, Dublin Compositions comprising oligosaccharides for treating prion disease
WO2007138048A1 (en) 2006-05-31 2007-12-06 Glaxo Group Limited Novel heterocyclic compounds
WO2008019887A2 (en) 2006-08-18 2008-02-21 Organobalance Gmbh Probiotic microorganisms for the reduction of manure odor
US20080053490A1 (en) 2006-09-01 2008-03-06 Bausch & Lomb Incorporated Method for hydrating a contact lens
US20080107699A1 (en) 2006-10-25 2008-05-08 Mark Spigelman Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor
AU2008211199A1 (en) 2007-01-26 2008-08-07 The Regents Of The University Of Colorado Methods of modulating immune function
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
CN102036670A (zh) 2007-02-01 2011-04-27 爱默思公司 用于减轻哺乳动物炎症和氧化应激反应的方法
RU2407401C2 (ru) 2007-02-13 2010-12-27 Общество С Ограниченной Ответственностью "Марс" Способ кормления собак
JP2010522246A (ja) 2007-03-27 2010-07-01 ザ プロクター アンド ギャンブル カンパニー プロバイオティクスを投与するための方法及びキット
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
AU2009291899B2 (en) 2008-09-11 2014-05-22 Mars, Incorporated Animal feed kibble with protein-based core and related methods
US8691303B2 (en) 2009-07-31 2014-04-08 The Iams Company Dusted animal food
CN102791134B (zh) 2009-12-04 2015-04-22 魄金莱默有限公司 用多巴胺再摄取抑制剂及类似物治疗糖尿病症状和延迟或预防糖尿病相关病理学病况的方法
US20120115798A1 (en) 2010-11-04 2012-05-10 Stefan Patrick Massimino Method for improving the immunity of a companion animal
FR2969496B1 (fr) 2010-12-22 2013-11-08 Expanscience Lab Extrait de pulpe et/ou de peau d'avocat riche en polyphenols et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
US20120282373A1 (en) 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite and Selenium
US20120283197A1 (en) 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
CA2879784C (en) 2012-07-25 2020-09-15 Agrofresh Inc. Methods of handling avocados and system
US20140349002A1 (en) 2013-05-23 2014-11-27 The Iams Company Ingestible Compositions Containing Criollo Avocado Component
US20140348986A1 (en) 2013-05-23 2014-11-27 The Iams Company Avocado Processing
EP2805721B1 (en) 2013-05-23 2018-09-05 IAMS Europe B.V. Mimicking the metabolic effect of caloric restrictions by administration of glucose anti-metabolites to enhance positive response in a mammal
CA2929933A1 (en) 2013-11-11 2015-05-14 The Iams Company Processes for preparing a carbohydrate extract comprising mannoheptulose and compositions comprising same

Also Published As

Publication number Publication date
WO2008093303A3 (en) 2008-09-25
CA2673465A1 (en) 2008-08-07
AU2008211600A1 (en) 2008-08-07
BRPI0808391A2 (pt) 2014-07-08
ES2551719T3 (es) 2015-11-23
JP5799299B2 (ja) 2015-10-21
EP2124966B1 (en) 2015-09-09
PL2124966T3 (pl) 2016-01-29
AR065145A1 (es) 2009-05-20
CN101711158A (zh) 2010-05-19
RU2009127329A (ru) 2011-03-10
RU2436581C2 (ru) 2011-12-20
JP2010516806A (ja) 2010-05-20
EP2124966A2 (en) 2009-12-02
US20080260866A1 (en) 2008-10-23
WO2008093303A2 (en) 2008-08-07
AU2008211600B2 (en) 2014-01-23
JP2015157835A (ja) 2015-09-03
US9415083B2 (en) 2016-08-16
AU2008211600B8 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
MX2009008166A (es) Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
MX2009008165A (es) Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos.
HK1200714A1 (en) Fgfr-binder-active agent conjugates
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
MY184914A (en) Methods of administering pirfenidone theraphy
EP2705850A3 (en) Super fast-acting insulin compositions
WO2008086462A3 (en) AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS
WO2010017196A3 (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
WO2007144175A3 (en) Pharmaceutical composition comprising hydrochlorothiazide and telmisartan
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
EA201001285A1 (ru) Применение 25-oh d3 для воздействия на физиологию мышц человека
WO2012064667A3 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
MY149028A (en) Nalmefene hydrochloride dihydrate
MX2010000266A (es) Un método para disminuir los síntomas del consumo de alcohol.
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
WO2009124294A3 (en) Pharmaceutical compositions for binding sphingosine-1-phosphate
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
EA201100730A1 (ru) Комплекс включения пиноцембрина с циклодекстрином, способ его получения и применения
WO2008042841A3 (en) Docetaxel compositions
BR112012015449A2 (pt) suspensão de monoidrato de calcipotriol, monoidrato de calcipotriol, processo para preparar nanocristais de monoidrato de calcipotriol, e, composição farmacêutica
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
EA200870148A1 (ru) Производные сулиндака, их применение и получение

Legal Events

Date Code Title Description
FG Grant or registration